Inflammatory markers should be the basis of monitoring asthma. The case for the pro's

Paediatric Respiratory Reviews

Volumn 7, Issue SUPPL. 1, 2006, Pages

  Stick, Stephen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CYTOKINE; ISOPROSTANE; LEUKOTRIENE; MANNITOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM CHLORIDE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

ARTICLE; ASTHMA; BREATH ANALYSIS; BRONCHUS BIOPSY; CLINICAL TRIAL; COCHRANE LIBRARY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; EXHALATION; HUMAN; LUNG FUNCTION; LUNG LAVAGE; METHODOLOGY; NON INVASIVE MEASUREMENT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT INFLAMMATION; SAFETY; SPUTUM ANALYSIS; SYMPTOM; TREATMENT OUTCOME;

EID: 33745212453     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2006.04.226     Document Type: Note

References (20)

1. Holgate S.T. Inflammatory and structural changes in the airways of patients with asthma. Respir Med 94 Suppl D (2000) S3-S6
2. Keatings V.M., Evans D.J., O'Connor B.J., and Barnes P.J. Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 52 (1997) 372-374
3. Gibson P. Use of induced sputum to examine airway inflammation in childhood asthma. JACI 102 (1998) S100-S101
4. Faul J.L., Demers E.A., Burke C.M., and Poulter L.W. The reproducibility of repeat measures of airway inflammation in stable atopic asthma. Am J Respir Crit Care Med 160 5 Pt 1 (1999) 1457-1461
5. Leuppi J.D., Salome C.M., Jenkins C.R., Anderson S.D., Xuan W.E.I., Marks G.B., et al. Predictive Markers of Asthma Exacerbation during Stepwise Dose Reduction of Inhaled Corticosteroids. Am J Respir Crit Care Med 163 (2001) 406-412
6. Boushey H.A., Sorkness C.A., King T.S., Sullivan S.D., Fahy J.V., Lazarus S.C., et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 352 (2005) 1519-1528
7. Sin D.D., Man J., Sharpe H., Gan W.Q., and Man S.F. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. Jama 292 (2004) 367-376
8. Masoli M., Weatherall M., Holt S., and Beasley R. Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child 89 (2004) 902-907
9. van Grunsven P.M., van Schayck C.P., Molema J., Akkermans R.P., and van Weel C. Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis. Thorax 54 (1999) 316-322
10. Djukanovic R., Homeyard S., Gratziou C., Madden J., Walls A., Montefort S., et al. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am J Respir Crit Care Med 155 (1997) 826-832
11. Djukanovic R., Wilson J.W., Britten K.M., Wilson S.J., Walls A.F., Roche W.R., et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145 (1992) 669-674
12. Franklin P.J., Turner S.W., Mutch R.C., and Stick S.M. Comparison of single-breath and tidal breathing exhaled nitric oxide levels in infants. Eur Respir J 23 (2004) 369-372
13. Moeller A., Franklin P., Hall G.L., Horak Jr. F., Wildhaber J.H., and Stick S.M. Measuring exhaled breath condensates in infants. Pediatr Pulmonol 41 (2006) 184-187
14. Baraldi E., and Jongste J.d. Measurement of exhaled nitric oxide in children, 2001. Eur J Respir Dis 20 (2001) 223-237
15. Franklin P.J., Turner S.W., Le Souëf P.N., and Stick S.M. Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax 58 (2003) 1048-1052
16. Franklin P.J., Turner S.W., Hall G.L., Moeller A., and Stick S.M. Exhaled nitric oxide is reduced in infants with rhinorrhea. Pediatr Pulmonol (2004)
17. Simpson J.L., Wood L.G., and Gibson P.G. Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy 35 (2005) 1180-1185
18. Truyen E., Coteur L., Dilissen E., Overbergh L., Dupont L.J., Ceuppens J.L., et al. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax 61 (2006) 202-208
19. Sont J.K., Willems L.N.A., Bel E.H., van Krieken J.H.J.M., Vandenbroucke J.P., Sterk P.J., et al. Clinical Control and Histopathologic Outcome of Asthma when Using Airway Hyperresponsiveness as an Additional Guide to Long-Term Treatment. Am J Respir Crit Care Med 159 (1999) 1043-1051
20. Pijnenburg M.W., Bakker E.M., Hop W.C., and De Jongste J.C. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 172 (2005) 831-836